Depression trials recruiting in Kansas

All Depression trials nationally

Cities in Kansas

Recruiting trials in Kansas

• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
  NCT03887715 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
  NCT06223880 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Kansas: Overland Park
• E-Mindfulness Approaches for Living After Breast Cancer
  NCT06748222 · Phase: Phase 3 · Ages: 18 Years to 50 Years · Sex: All (male and female) · Kansas: Topeka
• ENA-001 for Opioid Induced Respiratory Depression
  NCT06967259 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Kansas: Overland Park
• Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
  NCT06085937 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Kansas: Kansas City
• Promoting Active Therapy: Path to Wellness
  NCT06858189 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Kansas: Manhattan
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
  NCT07002034 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Kansas: Kansas City
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
  NCT05850689 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Kansas: Kansas City, Overland Park
• Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
  NCT06547489 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · Kansas: Wichita